Jakarta, Dec. 3 -- The Indonesian government is continuing clinical trials for a dengue vaccine to minimize the spread of the virus.

The Food and Drug Monitoring Agency (BPOM) issued approval for this clinical trial in August 2025.

"The clinical trial of the V181-005 vaccine has the potential to introduce innovations to improve compliance and accelerate protection for children," said BPOM Head Taruna Ikrar in a statement in Jakarta on Wednesday.

The advanced clinical trial was continued due to the high number of dengue cases in Indonesia.

Data from the World Health Organization (WHO) in 2024 recorded more than 257,000 cases and 1,400 deaths due to dengue in Indonesia.

Meanwhile, a study found that dengue infections in Indonesia cause...